The Salt Lake Tribune
Some 1,500 Utah adults with insurance coverage through Medicaid have developed diabetes because they took the antipsychotic drug Zyprexa, Utah’s Attorney General estimates.
The state has filed a lawsuit against Zyprexa’s manufacturer, Eli Lilly & Co., charging that the company improperly promoted the drug and failed to warn patients of adverse side effects that include diabetes, severe weight gain and pancreatitis.
About 100 Utah patients have already individually sued Eli Lilly, according to assistant Attorney General David Stallard. Others “may not have any idea that Zyprexa had anything to do with them developing diabetes,” he said.
Utah accuses Eli Lilly of pushing doctors to prescribe the drug to Utah Medicaid patients to treat “off-label” conditions like Tourette’s syndrome, Alzheimer’s and anorexia…